Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

In this week’s Phispers, we bring you the split story of two GLP-1 drugmakers — Eli Lilly and Novo Nordisk. While L...

Impressions : 548

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

Public health suffered several setbacks over the last week. First, the United States formally exited the World Health Organiza...

Impressions : 1251

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

In 2022, Pfizer had crossed US$ 100 billion in revenue owing to its Covid products. While that was a one-off, Johnson & Johnson...

Impressions : 1141

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

This week’s Phispers is packed with news from the ongoing JP Morgan Healthcare Conference (JPM26). Notably, AbbVie said i...

Impressions : 1143

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

Qilu Pharm Hainan's Generics Carboplatin Receives Approval in US

Avyxa's Vykoura Receives Approval in US

Qilu Pharm's Generics Doxorubicin HCl Receives Approval in US

Kindos' Generics Selenious Acid Receives Approval in US

Novitium Pharma's Generics Mirtazapine Receives Approval in US

Apotex's Generics Fidaxomicin Receives Approval in US

Long Grove Pharms' Generics Estradiol Receives Approval in US

Cipla's Generics Lenalidomide Receives Approval in US

Zydus' Generics Dapagliflozin Receives Tentative Approval in US

Vis' Yuvezzi Receives Approval in US

Enforcement Report - Week of February 4, 2026

Panacea Biotec Limited Fails EDQM Inspection

FD A Issues Form 483 toUS Specialty Formulations

Hebei Shengxue Dacheng Pharmaceutical Fails EDQM Inspection

Hangzhou Yiqi Biotechnology is on FDA Import Alert List

FDA Issues Form 483 to InnoStar Bio-Tech Nantong

FDA Issues Form 483 to JKR Pharmacy Ventures

Enforcement Report - Week of January 28, 2026

Center For Immunology's Receives FDA Warning Letter

Fulijaya Manufacturing SDN BHD's Receives FDA Warning Letter

LT3001 Shows FUNCTIONAL IMPROVEMENTS IN ACUTE ISCHEMIC STROKE

CVS Pharmacy Now Accepting Trumprx Discount Cards

Azitra Adjourns Special Meeting, Sets Reconvened Meeting

Congress Advances Spending Package For NABIP Healthcare

Wipro Seeks Schedule M Exemption For Tumkur Plant, Regulator

Kura Oncology Discloses Inducement Grants Per Nasdaq Lr

VALNEVA Declaration Of Shares And Voting Rights: January 31, 2026

Pulmovant Completes Phase 2 Study Enrollment For Mosliciguat

Immunovant Reports Q3 Financial Results And Corporate Updates

Priovant Reports Positive Phase 2 Data For Brepocitinib

Makary Criticizes 'Illegal Copycat Drugs' Amid Hims' Compounded

Alembic Pharma Receives USFDA Approval For Generic Parkinson's

Bridgebio Shares Slide On Pfizer's ATTR Patent Withdrawal

FDA Proposes Waiving GDUFA Fees for Domestic Facilities

Hims & Hers Plans To Launch $49 Copy Of Wegovy Pill

Lupin Introduces Topiramate Extended-Release Capsules In US

Zydus Receives USFDA Tentative Approval For Dapagliflozin Tablets

NATCO Receives Fda's Tentative Approval For Erdafitinib Tablets

National Pharmaceutical Pricing Authority Sets Retail Prices

Lupin Launches Dasatinib Tablets In The United States

Azitra Adjourns Special Meeting, Sets Reconvened Meeting

Pulmovant Completes Phase 2 Study Enrollment For Mosliciguat

Priovant Reports Positive Phase 2 Data For Brepocitinib

Roivant Reports Positive Phase 2 Data For Brepocitinib

Uniqure Reveals AMT-191 Phase I/Iia Data: Sustained ?-Gal A

Intellia Therapeutics Discloses Inducement Grants Per Nasdaq Lr

TG Therapeutics Presents BRIUMVI® Data In Multiple Sclerosis

Clearmind Medicine Partners To Develop Intranasal MEAI

Taysha Gene Therapies Grants Inducement Under Nasdaq Lr

Immutep Reaches 50% Enrollment In Global Phase III Trial For 1L

Sun Pharma To Pump In Rs 500 Cr In Assam Manufacturing Unit

Bdmai Launches E-Marketing Portal For Indian Pharma Expansion

Fis Successfully Completes €770 Million Bond Issuance

Wanbury Reaches First Sales Invoicing Shipment Milestone

Piramal Pharma Solutions Launches Tablet-In-Capsule Services

Lilly Drafts Plan For Last Of 4 New US Drug Manufacturing Plants

FDA Launches Program to Boost Domestic Drug Manufacturing

Wanbury Reveals Tanuku API Facility, Aims For Rs. 100 Crore

Minimum Import Price Set For Penicillin G, Salts

Beyond the Label What Defines Pharma-Grade Mupirocin Calcium API

Wipro Seeks Schedule M Exemption For Tumkur Plant, Regulator

FDA Enhances Post-Approval Product Change Oversight

Health Ministry Amends NDCT Rules For Post-Approval Change

Pharma Expert Addresses Standardizing CMC Quality Data

FDA: Initiates QMSR And Precheck Programs, Makary Addresses CNPV

Industry Pushes For Automatic Post-Inspection Meetings Post-483

Trividia Health Starts Labeling Correction For TRUE METRIX®

Biocomposites Secures MDR Certification For STIMULAN? Rapid Cure

FDA Commissioner Pledges Crackdown On Compounding Practices

Novo Nordisk Addresses Hims & Hers' Illegal Compounding

LT3001 Shows FUNCTIONAL IMPROVEMENTS IN ACUTE ISCHEMIC STROKE

Humans Show Bat-Like Skills Using Mouth-Click Echolocation

Microbot Medical To Showcase LIBERTY® Robotic System At Oncology